News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
357,816 Results
Type
Article (22281)
Company Profile (140)
Press Release (335394)
Multimedia
Podcasts (79)
Webinars (13)
Section
Business (109905)
Career Advice (903)
Deals (19103)
Drug Delivery (100)
Drug Development (53718)
Employer Resources (84)
FDA (8211)
Job Trends (8236)
News (194364)
Policy (18302)
Tag
Academia (934)
Accelerated approval (4)
Adcomms (20)
Allergies (54)
Alliances (29396)
ALS (77)
Alzheimer's disease (754)
Antibody-drug conjugate (ADC) (115)
Approvals (8225)
Artificial intelligence (176)
Autoimmune disease (20)
Automation (7)
Bankruptcy (179)
Best Places to Work (6039)
BIOSECURE Act (13)
Biosimilars (101)
Biotechnology (67)
Bladder cancer (51)
Brain cancer (24)
Breast cancer (157)
Cancer (1478)
Cardiovascular disease (135)
Career advice (735)
Career pathing (22)
CAR-T (81)
CDC (6)
Cell therapy (216)
Cervical cancer (7)
Clinical research (45302)
Collaboration (604)
Compensation (226)
Complete response letters (24)
COVID-19 (1225)
CRISPR (41)
C-suite (202)
Cystic fibrosis (79)
Data (1658)
Decentralized trials (2)
Denatured (19)
Depression (32)
Diabetes (187)
Diagnostics (2007)
Digital health (6)
Diversity (7)
Diversity, equity & inclusion (23)
Drug discovery (96)
Drug pricing (131)
Drug shortages (32)
Duchenne muscular dystrophy (86)
Earnings (40687)
Editorial (35)
Employer branding (11)
Employer resources (78)
Events (52964)
Executive appointments (555)
FDA (9040)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (437)
Gene editing (80)
Generative AI (18)
Gene therapy (204)
GLP-1 (646)
Government (2087)
Grass and pollen (3)
Guidances (94)
Healthcare (6893)
Huntington's disease (18)
IgA nephropathy (30)
Immunology and inflammation (103)
Immuno-oncology (7)
Indications (24)
Infectious disease (1317)
Inflammatory bowel disease (100)
Inflation Reduction Act (9)
Influenza (27)
Intellectual property (73)
Interviews (121)
IPO (7756)
IRA (47)
Job creations (2472)
Job search strategy (664)
Kidney cancer (9)
Labor market (34)
Layoffs (301)
Leadership (16)
Legal (4260)
Liver cancer (35)
Lung cancer (222)
Lymphoma (132)
Machine learning (5)
Management (31)
Manufacturing (267)
MASH (63)
Medical device (2215)
Medtech (2218)
Mergers & acquisitions (11689)
Metabolic disorders (602)
Multiple sclerosis (62)
NASH (20)
Neurodegenerative disease (66)
Neuropsychiatric disorders (25)
Neuroscience (1172)
NextGen: Class of 2025 (2736)
Non-profit (2012)
Now hiring (27)
Obesity (360)
Opinion (207)
Ovarian cancer (43)
Pain (84)
Pancreatic cancer (54)
Parkinson's disease (103)
Partnered (12)
Patents (180)
Patient recruitment (71)
Peanut (22)
People (35130)
Pharmaceutical (75)
Pharmacy benefit managers (24)
Phase I (14229)
Phase II (19251)
Phase III (15363)
Pipeline (1001)
Policy (155)
Postmarket research (1698)
Preclinical (5124)
Press Release (30)
Prostate cancer (82)
Psychedelics (18)
Radiopharmaceuticals (166)
Rare diseases (315)
Real estate (3277)
Recruiting (31)
Regulatory (13399)
Reports (24)
Research institute (1175)
Resumes & cover letters (142)
Rett syndrome (2)
RNA editing (8)
RSV (28)
Schizophrenia (69)
Series A (77)
Series B (49)
Service/supplier (7)
Sickle cell disease (47)
Special edition (18)
Spinal muscular atrophy (129)
Sponsored (15)
Startups (2131)
State (2)
Stomach cancer (9)
Supply chain (57)
Tariffs (60)
The Weekly (58)
Vaccines (330)
Venture capitalists (36)
Weight loss (256)
Women's health (15)
Worklife (8)
Date
Today (97)
Last 7 days (313)
Last 30 days (1366)
Last 365 days (17464)
2025 (8329)
2024 (19036)
2023 (21131)
2022 (27728)
2021 (28769)
2020 (26865)
2019 (22016)
2018 (17052)
2017 (18245)
2016 (17365)
2015 (20052)
2014 (15632)
2013 (13204)
2012 (14020)
2011 (14407)
2010 (13252)
Location
Africa (441)
Alabama (27)
Alaska (3)
Arizona (74)
Arkansas (8)
Asia (25947)
Australia (3445)
California (3373)
Canada (1349)
China (437)
Colorado (122)
Connecticut (129)
Delaware (103)
Europe (54135)
Florida (572)
Georgia (74)
Idaho (23)
Illinois (311)
India (21)
Indiana (196)
Iowa (4)
Japan (166)
Kansas (74)
Kentucky (23)
Louisiana (4)
Maine (4)
Maryland (486)
Massachusetts (2776)
Michigan (54)
Minnesota (166)
Mississippi (2)
Missouri (29)
Montana (10)
Nebraska (11)
Nevada (27)
New Hampshire (9)
New Jersey (1292)
New Mexico (21)
New York (1013)
North Carolina (641)
North Dakota (4)
Northern California (1467)
Ohio (112)
Oklahoma (5)
Oregon (22)
Pennsylvania (752)
Puerto Rico (14)
Rhode Island (20)
South America (632)
South Carolina (5)
Southern California (1360)
Tennessee (45)
Texas (449)
United States (13155)
Utah (70)
Virginia (116)
Washington D.C. (54)
Washington State (268)
West Virginia (1)
Wisconsin (33)
357,816 Results for "cure pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Infectious disease
Biopharma Targets an HIV Cure as NIH Funding Cuts Threaten To Derail Progress
As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are targeting the next goalpost: a cure.
May 12, 2025
·
7 min read
·
Heather McKenzie
Press Releases
Code Pharma’s Gammora® Demonstrates Highly Favorable Outcomes Toward a Potential Cure for HIV
November 13, 2024
·
2 min read
Pharm Country
Mitsubishi Tanabe Pharma America Presents New Results of RADICAVA® (edaravone) for People Living with ALS at the European Network to Cure ALS (ENCALS) Meeting 2024
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced results from two studies of RADICAVA® (edaravone) for amyotrophic lateral sclerosis (ALS) at the European Network to Cure Amyotrophic Lateral Sclerosis (ENCALS) 2024 meeting.
June 17, 2024
·
8 min read
Clinical research
Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond
R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.
May 28, 2025
·
12 min read
·
Tristan Manalac
Press Releases
Cure Rare Disease Welcomes New Scientific and Strategic Leaders to Advance Therapies for Ultra-Rare Conditions
June 10, 2025
·
3 min read
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
The National Children’s Cancer Society (NCCS) Celebrates 20 Years of the Beyond the Cure Survivorship Program
May 29, 2025
·
5 min read
Compensation
Top 6 Highest-Paid Pharma CEOs in 2024
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
April 16, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
Notice To Extraordinary General Meeting In Alzecure Pharma AB
June 16, 2025
·
7 min read
Europe
With Tariffs Looming, EU and US Pharmas Make Demands of European Commission
Playing both sides of trade war, pharma companies are asking for certain compensations for scientific innovation and a smoother regulatory framework.
April 16, 2025
·
2 min read
·
Tristan Manalac
1 of 35,782
Next
